Lindbrook Capital’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-383
| Closed | -$402 | – | 2645 |
|
|
2023
Q4 | $402 | Buy |
383
+99
| +35% | +$104 | ﹤0.01% | 2596 |
|
|
2023
Q3 | $1.95K | Buy |
284
+250
| +735% | +$1.71K | ﹤0.01% | 2140 |
|
|
2023
Q2 | $353 | Buy |
+34
| New | +$353 | ﹤0.01% | 2577 |
|
|
2023
Q1 | – | Sell |
-208
| Closed | -$3.28K | – | 2770 |
|
|
2022
Q4 | $3.28K | Sell |
208
-31
| -13% | -$488 | ﹤0.01% | 2012 |
|
|
2022
Q3 | $4K | Buy |
239
+31
| +15% | +$519 | ﹤0.01% | 1720 |
|
|
2022
Q2 | $3K | Hold |
208
| – | – | ﹤0.01% | 1730 |
|
|
2022
Q1 | $4K | Buy |
+208
| New | +$4K | ﹤0.01% | 1662 |
|